Lung transplantation for sarcoidosis: outcome and prognostic factors
- 21 January 2021
- journal article
- research article
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 58 (2), 2003358
- https://doi.org/10.1183/13993003.03358-2020
Abstract
Study question In patients with sarcoidosis, past and ongoing immunosuppressive regimens, recurrent disease in the transplant, and extrapulmonary involvement may affect outcomes of lung transplantation. We asked whether sarcoidosis lung phenotypes can be differentiated and, if so, how they relate to outcomes in patients with pulmonary sarcoidosis treated by lung transplantation. Patients and methods We retrospectively reviewed data from 112 patients who met international diagnostic criteria for sarcoidosis and underwent lung or heart-lung transplantation between 2006 and 2019 at 16 European centres. Results Patient survival was the main outcome measure. At transplantation, median age was 52 [46–59] years; 71 (64%) were male. Lung phenotypes were individualised as follows (i) extended fibrosis only; (ii) airflow obstruction; (iii) severe pulmonary hypertension (sPH) and airflow obstruction; (iv) sPH, airflow obstruction, and fibrosis, (v) sPH and fibrosis, (vi) airflow obstruction and fibrosis, (vii) sPH and (viii) none of these criteria, in 17%, 16%, 17%, 14%, 11%, 9%, 5% and 11% of patients, respectively. Posttransplant survival rates after 1, 3, and 5 years were 86%, 76%, and 69%, respectively. During follow-up (median, 46 [16–89] months), 31% of patients developed chronic lung allograft dysfunction. Age and extended lung fibrosis were associated with increased mortality. Pulmonary fibrosis predominating peripherally was associated with short-term complications. Answer to the study question Posttransplant survival in patients with pulmonary sarcoidosis was similar to that in patients with other indications for lung transplantation. The main factors associated with worse survival were older age and extensive preoperative lung fibrosis.This publication has 36 references indexed in Scilit:
- Management of end-stage sarcoidosis: pulmonary hypertension and lung transplantationEuropean Respiratory Journal, 2012
- Serial Development of Pulmonary Hypertension in Patients with Idiopathic Pulmonary FibrosisRespiration, 2008
- Evidence of Innervation in Talc-Induced Pleural AdhesionsSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2006
- Effect of Preoperative Pulmonary Artery Pressure on Early Survival After Lung Transplantation for Idiopathic Pulmonary FibrosisThe Journal of Heart and Lung Transplantation, 2005
- Recurrent Sarcoidosis in Lung Transplant AllograftsDiagnostic Molecular Pathology, 2005
- Graft Ischemic Time and Outcome of Lung TransplantationAmerican Journal of Respiratory and Critical Care Medicine, 2005
- Clinical Characteristics of Patients in a Case Control Study of SarcoidosisAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Frequency and CT Findings of Recurrent Disease after Lung TransplantationRadiology, 2001
- Recurrence of Sarcoidosis Following Bilateral Allogeneic Lung TransplantationSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 1994
- The Bronchial Arteries in Pulmonary EmphysemaThorax, 1953